SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-001563
Filing Date
2022-01-11
Accepted
2022-01-11 16:45:29
Documents
45
Period of Report
2021-11-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1121_oramedpharma.htm   iXBRL 10-Q 623758
2 CERTIFICATION f10q1121ex31-1_oramedpharma.htm EX-31.1 7470
3 CERTIFICATION f10q1121ex31-2_oramedpharma.htm EX-31.2 7963
4 CERTIFICATION f10q1121ex32-1_oramedpharma.htm EX-32.1 3087
5 CERTIFICATION f10q1121ex32-2_oramedpharma.htm EX-32.2 3107
  Complete submission text file 0001213900-22-001563.txt   3243849

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ormp-20211130.xsd EX-101.SCH 36495
7 XBRL CALCULATION FILE ormp-20211130_cal.xml EX-101.CAL 28720
8 XBRL DEFINITION FILE ormp-20211130_def.xml EX-101.DEF 169078
9 XBRL LABEL FILE ormp-20211130_lab.xml EX-101.LAB 340162
10 XBRL PRESENTATION FILE ormp-20211130_pre.xml EX-101.PRE 173159
39 EXTRACTED XBRL INSTANCE DOCUMENT f10q1121_oramedpharma_htm.xml XML 303719
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 001-35813 | Film No.: 22524446
SIC: 2834 Pharmaceutical Preparations